Combining Brachytherapy and Cryotherapy as Adjuvant Therapy for Squamous Cell Carcinoma of the Conjunctiva: Literature Review and Case Reports

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

Combining Brachytherapy and Cryotherapy as Adjuvant Therapy for Squamous Cell Carcinoma of the Conjunctiva : Literature Review and Case Reports. / Fagerberg, Peter S.; Ramberg, Ingvild M.S.; Toft, Peter B.

I: Ocular Oncology and Pathology, Bind 2021, Nr. 7, 2021, s. 77–84.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

Fagerberg, PS, Ramberg, IMS & Toft, PB 2021, 'Combining Brachytherapy and Cryotherapy as Adjuvant Therapy for Squamous Cell Carcinoma of the Conjunctiva: Literature Review and Case Reports', Ocular Oncology and Pathology, bind 2021, nr. 7, s. 77–84. https://doi.org/10.1159/000512029

APA

Fagerberg, P. S., Ramberg, I. M. S., & Toft, P. B. (2021). Combining Brachytherapy and Cryotherapy as Adjuvant Therapy for Squamous Cell Carcinoma of the Conjunctiva: Literature Review and Case Reports. Ocular Oncology and Pathology, 2021(7), 77–84. https://doi.org/10.1159/000512029

Vancouver

Fagerberg PS, Ramberg IMS, Toft PB. Combining Brachytherapy and Cryotherapy as Adjuvant Therapy for Squamous Cell Carcinoma of the Conjunctiva: Literature Review and Case Reports. Ocular Oncology and Pathology. 2021;2021(7):77–84. https://doi.org/10.1159/000512029

Author

Fagerberg, Peter S. ; Ramberg, Ingvild M.S. ; Toft, Peter B. / Combining Brachytherapy and Cryotherapy as Adjuvant Therapy for Squamous Cell Carcinoma of the Conjunctiva : Literature Review and Case Reports. I: Ocular Oncology and Pathology. 2021 ; Bind 2021, Nr. 7. s. 77–84.

Bibtex

@article{78d684902c9f48bead85d21d84015c41,
title = "Combining Brachytherapy and Cryotherapy as Adjuvant Therapy for Squamous Cell Carcinoma of the Conjunctiva: Literature Review and Case Reports",
abstract = "Background: Separately, cryotherapy and brachytherapy have shown promising results when adjuvating the excision of squamous cell carcinoma of the conjunctiva (SCCC). The aim of this paper is to assess the combined effect in terms of complications and recurrence rate. Summary: We describe 2 patients suffering from SCCC, and we review the current literature on adjuvant cryotherapy and brachytherapy. Both patients, one of whom suffered from recurrent SCCC, underwent surgical excision followed by combined cryotherapy and brachytherapy. Cryotherapy was performed using a retinal cryoprobe, and 2 rounds each of 5 s with N2O as a cryogen were applied. Brachytherapy was performed using a ruthenium-106 plaque, delivering a dosage of 100 Gy at 2-mm depth. Key Messages: By reviewing the current literature and describing 2 case reports, this paper illustrates the use of combined cryotherapy and brachytherapy after surgical excision of SCCC. The current literature presents promising results of each treatment, and the 2 cases showed promising results by combining the 2 adjuvant therapies showing no signs of recurrence or complications during a follow-up period of 26 and 38 months. ",
keywords = "Adjuvant therapy, Brachytherapy, Conjunctiva, Cryotherapy, Squamous cell carcinoma",
author = "Fagerberg, {Peter S.} and Ramberg, {Ingvild M.S.} and Toft, {Peter B.}",
year = "2021",
doi = "10.1159/000512029",
language = "English",
volume = "2021",
pages = "77–84",
journal = "Ocular Oncology and Pathology",
issn = "2296-4681",
publisher = "S Karger AG",
number = "7",

}

RIS

TY - JOUR

T1 - Combining Brachytherapy and Cryotherapy as Adjuvant Therapy for Squamous Cell Carcinoma of the Conjunctiva

T2 - Literature Review and Case Reports

AU - Fagerberg, Peter S.

AU - Ramberg, Ingvild M.S.

AU - Toft, Peter B.

PY - 2021

Y1 - 2021

N2 - Background: Separately, cryotherapy and brachytherapy have shown promising results when adjuvating the excision of squamous cell carcinoma of the conjunctiva (SCCC). The aim of this paper is to assess the combined effect in terms of complications and recurrence rate. Summary: We describe 2 patients suffering from SCCC, and we review the current literature on adjuvant cryotherapy and brachytherapy. Both patients, one of whom suffered from recurrent SCCC, underwent surgical excision followed by combined cryotherapy and brachytherapy. Cryotherapy was performed using a retinal cryoprobe, and 2 rounds each of 5 s with N2O as a cryogen were applied. Brachytherapy was performed using a ruthenium-106 plaque, delivering a dosage of 100 Gy at 2-mm depth. Key Messages: By reviewing the current literature and describing 2 case reports, this paper illustrates the use of combined cryotherapy and brachytherapy after surgical excision of SCCC. The current literature presents promising results of each treatment, and the 2 cases showed promising results by combining the 2 adjuvant therapies showing no signs of recurrence or complications during a follow-up period of 26 and 38 months.

AB - Background: Separately, cryotherapy and brachytherapy have shown promising results when adjuvating the excision of squamous cell carcinoma of the conjunctiva (SCCC). The aim of this paper is to assess the combined effect in terms of complications and recurrence rate. Summary: We describe 2 patients suffering from SCCC, and we review the current literature on adjuvant cryotherapy and brachytherapy. Both patients, one of whom suffered from recurrent SCCC, underwent surgical excision followed by combined cryotherapy and brachytherapy. Cryotherapy was performed using a retinal cryoprobe, and 2 rounds each of 5 s with N2O as a cryogen were applied. Brachytherapy was performed using a ruthenium-106 plaque, delivering a dosage of 100 Gy at 2-mm depth. Key Messages: By reviewing the current literature and describing 2 case reports, this paper illustrates the use of combined cryotherapy and brachytherapy after surgical excision of SCCC. The current literature presents promising results of each treatment, and the 2 cases showed promising results by combining the 2 adjuvant therapies showing no signs of recurrence or complications during a follow-up period of 26 and 38 months.

KW - Adjuvant therapy

KW - Brachytherapy

KW - Conjunctiva

KW - Cryotherapy

KW - Squamous cell carcinoma

U2 - 10.1159/000512029

DO - 10.1159/000512029

M3 - Review

C2 - 33981690

AN - SCOPUS:85099730290

VL - 2021

SP - 77

EP - 84

JO - Ocular Oncology and Pathology

JF - Ocular Oncology and Pathology

SN - 2296-4681

IS - 7

ER -

ID: 256071418